Picture of Maravai Lifesciences Holdings logo

MRVI — Maravai Lifesciences Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Maravai Lifesciences Reports Q2 Financial Results

Aug 4 (Reuters) - Maravai LifeSciences Holdings Inc  MRVI.O :
    * MARAVAI LIFESCIENCES REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
    * MARAVAI LIFESCIENCES HOLDINGS INC -  QUARTERLY REVENUE OF $242.7 MILLION,
AN
INCREASE OF 11%
    * MARAVAI LIFESCIENCES HOLDINGS INC -  TOTAL REVENUE FOR 2022 IS PROJECTED
TO BE
IN RANGE OF $880.0 MILLION TO $910.0 MILLION
    * MARAVAI LIFESCIENCES HOLDINGS INC -  ADJUSTED FULLY DILUTED EPS (NON-GAAP)
IS
NOW EXPECTED TO BE IN RANGE OF $1.70 - $1.80 PER SHARE

Source text for Eikon:  ID:nGNX4Td6xb 
Further company coverage:  MRVI.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Maravai Lifesciences Holdings

See all news